Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma [Phase 4]
An open-label, single-arm Phase 4 trial evaluating a short-duration infusion of obinutuzumab in patients with previously untreated advanced …
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial of ABT-263 in relapsed or refractory lymphoid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]
A phase 1/2 trial investigating obinutuzumab with idasanutlin and venetoclax in relapsed/refractory follicular lymphoma and rituximab with i…
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: TGR1202 in Relapsed and Refractory Follicular Lymphoma [Phase 2]
Phase 2 trial update for TGR1202 in relapsed/refractory follicular lymphoma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) [Phase 1]
Phase 1 trial evaluating pembrolizumab (MK-3475) in blood cancers has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Adjustment of Chemotherapy Duration in Follicular Lymphoma According to Minimal Residual Disease Status [Phase 2]
Phase 2 trial exploring adjustment of chemotherapy duration in follicular lymphoma based on minimal residual disease status.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL) [Phase 3]
Phase 3 trial updates for GP2013 in previously untreated, advanced follicular lymphoma have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Phase 2]
Phase 2 trial evaluating lenalidomide with low-dose dexamethasone and rituximab in rituximab-resistant, non-aggressive B-cell lymphomas; com…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: FCM Versus R-FCM Followed by R-Maintenance or Observation Only [Phase 3]
Phase 3 trial comparing FCM vs R-FCM followed by R-maintenance or observation in follicular and low-grade lymphomas; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating bortezomib, rituximab, dexamethasone with or without temsirolimus in untreated or relapsed Waldenström macroglobu…
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study [Phase 4]
A multicenter Phase 4 trial evaluating rituximab maintenance after BR or RCHOP or R2 in newly diagnosed follicular lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma [Phase 3]
Phase 3 trial comparing CT-P10 to Rituxan in low tumor burden follicular lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial in Japanese participants assessing safety, tolerability, and pharmacokinetics of idelalisib in relapsed or refractory indolent…
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating sequential intranodal immunotherapy with anti-PD1 pembrolizumab in follicular lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating bendamustine with rituximab, with or without bortezomib, followed by rituximab with or without lenalidomide in high…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma [Phase 2]
Phase 2 clinical trial assessing SHC014748M for relapsed or refractory follicular lymphoma and marginal zone lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial update evaluating safety and efficacy of duvelisib in relapsed/refractory follicular lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma [Phase 2]
Phase 2 trial of atezolizumab with or without low-dose local radiation in relapsed/refractory advanced-stage follicular lymphoma was termina…
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103) [Phase 2]
Phase 2 study MK-0683-103 evaluated vorinostat in follicular lymphoma, other indolent B-cell non-Hodgkin lymphomas, and mantle cell lymphoma…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma [Phase 3]
Phase 3 trial comparing SAIT101 to Rituximab as first-line immunotherapy in low tumor burden follicular lymphoma has completed with results …
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies [Phase 2]
Phase 2 study evaluating entospletinib in adults with relapsed or refractory hematologic malignancies; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma [Phase 1]
Phase 1 trial evaluating pembrolizumab with combination chemotherapy in untreated diffuse large B-cell lymphoma and grade 3b follicular lymp…
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) [Phase 3]
Phase 3 study evaluating safety, efficacy, and pharmacokinetics of Rituximab in diffuse large B-cell lymphoma and follicular lymphoma has co…
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) [Phase 2]
Phase 2 clinical trial update for TQ-B3525 in relapsed/refractory follicular lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab in patients with diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma who f…